Viewing Study NCT06146348



Ignite Creation Date: 2024-05-06 @ 7:49 PM
Last Modification Date: 2024-10-26 @ 3:14 PM
Study NCT ID: NCT06146348
Status: RECRUITING
Last Update Posted: 2024-02-28
First Post: 2023-11-17

Brief Title: Deimplementing CXR After CVC DRAUP in the ICU
Sponsor: Washington University School of Medicine
Organization: Washington University School of Medicine

Study Overview

Official Title: Adapting and Testing a Deimplementation Program in the Intensive Care Unit
Status: RECRUITING
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study proposes adapting and testing an innovative behavioral theory-driven deimplementation program called DRAUP in two intensive care units for proof of concept and support that the program can help providers and hospital organizations address context determinants of deimplementation Study data will be used to optimize the intervention for a subsequent larger trials
Detailed Description: There are millions of critically ill patients annually who require imaging confirmation after central venous catheter insertion Emerging literature demonstrates that ultrasound is a faster alternative to historical chest xray thus serving as the ideal confirmation for catheter use When able to confirm catheter position ultrasound decreases the number of unnecessary chest radiographs cumulative resources technologist radiologist equipment and patient care delays However providers are not adopting this practice Previously we developed and initiated a successful evidence-based deimplementation program for ultrasound in lieu of chest xray called DRAUP in the Emergency Department We now move to adapt the deimplementation bundle in the new environment of the Intensive Care Unit ICU with hopeful continued success

In experiment 1 qualitative analysis will be employ a systematic approach to DRAUP component refinement dosed to the unique context of the Intensive Care Unit and implementation outcomes as well as cost will be evaluated In experiment 3 mixed methods will be used to evaluate the mechanism of impact of the refined program in the new environment

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
5K01HL161026-02 NIH None httpsreporternihgovquickSearch5K01HL161026-02